Clinical Trial

A Study to Evaluate the Efficacy and Safety of LZM012 ( Psoriasis )

Name: A Study to Evaluate the Efficacy and Safety of LZM012 ( Psoriasis ) — clinical trial record (NCT07746479)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 3

View on ClinicalTrials.gov →

Summary

This study is a Multicenter, Open-Label, Single-Arm Phase III Clinical Trial to Evaluate the Efficacy and Safety of LZM012 Injection in Patients With Moderate to Severe Plaque Psoriasis.

Trial Details

NCT Number	NCT07746479
Lead Sponsor	Livzon Pharmaceutical Group Inc.
Conditions	Psoriasis
Enrollment	244 participants
Start Date	2025-06-23
Primary Completion	2026-01-26 (estimated)
Study Completion	2026-01-26 (estimated)
Updated on ClinicalTrials.gov	2026-08-05